Ghrelin’s Role in Hyperphagia: A Distinguishing Biomarker for Rare Disorders
A recent cross-sectional study published in the Journal of Clinical Endocrinology & Metabolism investigates the hormonal drivers of hyperphagia and obesity in patients with rare genetic neurodevelopmental disorders (NDDs). The research, involving 130 patients across 27 distinct conditions, measured circulating levels of the hunger hormone ghrelin and assessed hyperphagia severity. The findings reveal that while hyperphagia is a common and severe feature, particularly in children with NDDs, elevated ghrelin levels (hyperghrelinemia) appear to be a specific biomarker for Prader-Willi syndrome (PWS). In contrast, patients with other rare NDDs exhibited ghrelin levels comparable to an obese control group, suggesting different underlying pathophysiological mechanisms for their excessive eating behaviors.
Study Significance: For specialists in reproductive endocrinology and infertility, this research underscores the importance of precise hormonal profiling in complex patient presentations. The identification of hyperghrelinemia as a specific marker for PWS can refine diagnostic pathways, which is crucial for genetic counseling and family planning in cases of syndromic obesity. Understanding these distinct endocrine signatures helps in tailoring targeted management strategies, moving beyond a one-size-fits-all approach to metabolic and appetite dysregulation seen in various genetic conditions.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
